Rare diseases
Investigational molecules
Locations
21823 30th Drive Southeast, 98021-3907, United States
Clinical research in urothelial carcinoma and bladder cancer includes locally advanced, metastatic, and non-muscle invasive disease, with additional attention to HER2-expressing and muscle invasive bladder cancer.
Research activity also extends to metastatic urothelial cancer and perioperative treatment settings.
Seagen Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Transitional cell carcinoma, Colorectal cancer metastatic, Endometrial cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
AustriaA study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors
The NetherlandsStudy of disitamab vedotin alone or with pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2
BelgiumStudy of Disitamab Vedotin for Adults with Previously Treated HER2-Positive Solid Tumors, Including Lung, Head and Neck, Ovarian, and Endometrial Cancers
FranceStudy of Disitamab Vedotin and Tucatinib for Patients with Advanced Breast Cancer or Gastric Cancer
FranceStudy of Disitamab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer Expressing HER2
BelgiumStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
BelgiumStudy of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors
FranceStudy of Tucatinib and Trastuzumab for Patients with Advanced Solid Tumors with HER2 Changes
BelgiumStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
AustriaStudy of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2
AustriaStudy on Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Urothelial Cancer
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
